Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 2Phase NA 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1

Conditions

Hemorrhage 1Hematologic Neoplasms 1Bone Neoplasms 1

Interventions

Cisplatin 186Carboplatin 181Paclitaxel 175Docetaxel 144Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 81Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 47Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Has results × Tranexamic Acid × Clear all
NCT03136445 2025-10-28

TREATT

NHS Blood and Transplant

Phase 3 Completed
616 enrolled 34 charts
Other hematologic neoplasm

Hemorrhage, Hematologic Neoplasms

NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡